Recently, Yun et al. [10] reported that the selective death of cancer cells with KRAS or BRAF mutation is caused by dehydroascorbate (DHA) by a targeting inactivation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) via the glucose transporter 1. This evidence concerns the gene KRAS and cancer.